30 TECHNOLOGY
Unlocking and delivering the promise of therapeutic Nitric Oxide.
Unlocking and delivering the promise of therapeutic Nitric Oxide.
30 TECHNOLOGY is a biotechnology and pharmaceutical startup based in the United Kingdom, founded in 2018. The company's slogan, "Unlocking and delivering the promise of therapeutic Nitric Oxide," encapsulates its mission of developing innovative models of care to address serious medical conditions. By harnessing the healing and defense mechanisms of the body, 30 TECHNOLOGY aims to revolutionize the treatment of various health issues.
Despite the absence of publicly available information regarding the last investment and its investors, the startup's focus on therapeutic Nitric Oxide presents an intriguing proposition in the biotechnology and pharmaceutical sectors. As the demand for advanced medical solutions continues to rise, 30 TECHNOLOGY's unique approach positions it as a compelling player in the industry.
There is no investment information
No recent news or press coverage available for 30 TECHNOLOGY.
We care about your data, and we'd love to use cookies make your experience better.
